Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility

Protein C inhibitor (PCI) is a nonspecific, heparin-binding serpin (serine protease inhibitor) that inactivates many plasmatic and extravascular serine proteases by forming stable 1:1 complexes. Proteases inhibited by PCI include the anticoagulant activated protein C, the plasminogen activator uroki...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of clinical investigation Vol. 106; no. 12; pp. 1531 - 1539
Main Authors Uhrin, P, Dewerchin, M, Hilpert, M, Chrenek, P, Schöfer, C, Zechmeister-Machhart, M, Krönke, G, Vales, A, Carmeliet, P, Binder, B R, Geiger, M
Format Journal Article
LanguageEnglish
Published United States American Society for Clinical Investigation 15.12.2000
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Protein C inhibitor (PCI) is a nonspecific, heparin-binding serpin (serine protease inhibitor) that inactivates many plasmatic and extravascular serine proteases by forming stable 1:1 complexes. Proteases inhibited by PCI include the anticoagulant activated protein C, the plasminogen activator urokinase, and the sperm protease acrosin. In humans PCI circulates as a plasma protein but is also present at high concentrations in organs of the male reproductive tract. The biological role of PCI has not been defined so far. However, the colocalization of high concentrations of PCI together with several of its target proteases in the male reproductive tract suggests a role of PCI in reproduction. We generated mice lacking PCI by homologous recombination. Here we show that PCI(-/-) mice are apparently healthy but that males of this genotype are infertile. Infertility was apparently caused by abnormal spermatogenesis due to destruction of the Sertoli cell barrier, perhaps due to unopposed proteolytic activity. The resulting sperm are malformed and are morphologically similar to abnormal sperm seen in some cases of human male infertility. This animal model might therefore be useful for analyzing the molecular bases of these human conditions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Address correspondence to: Margarethe Geiger, Department of Vascular Biology and Thrombosis Research, University of Vienna, Schwarzspanierstrasse 17, A-1090 Vienna, Austria. Phone: 43-1-4277-62506; Fax: 43-1-4277-9625; E-mail: margarethe.geiger@univie.ac.at.
ISSN:0021-9738
1558-8238
DOI:10.1172/jci10768